Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Journal Information
Full Title: Neoplasia
Abbreviation: Neoplasia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by 10.13039/501100001809National Natural Science Foundation of China (82104453); the Red Medical Famous teacher of Army Medical University (Rong Zhang); the Red Medical Talent Project of Army Medical University (Wuyi Liu) and the Chongqing Key Specialty Construction Project of Clinical Pharmacy (Clinical Pharmacy of Medical oncology)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025